Cite
Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study.
MLA
Liatsou, Ioanna, et al. “Therapeutic Efficacy of an Alpha-Particle Emitter Labeled Anti-GD2 Humanized Antibody against Osteosarcoma—a Proof of Concept Study.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 51, no. 5, Apr. 2024, pp. 1409–20. EBSCOhost, https://doi.org/10.1007/s00259-023-06528-2.
APA
Liatsou, I., Fu, Y., Li, Z., Hasan, M., Guo, X., Yu, J., Piccolo, J., Cartee, A., Wang, H., Du, Y., Bryan, J., Gabrielson, K., Kraitchman, D. L., & Sgouros, G. (2024). Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma—a proof of concept study. European Journal of Nuclear Medicine & Molecular Imaging, 51(5), 1409–1420. https://doi.org/10.1007/s00259-023-06528-2
Chicago
Liatsou, Ioanna, Yingli Fu, Zhi Li, Mahmud Hasan, Xin Guo, Jing Yu, Joseph Piccolo, et al. 2024. “Therapeutic Efficacy of an Alpha-Particle Emitter Labeled Anti-GD2 Humanized Antibody against Osteosarcoma—a Proof of Concept Study.” European Journal of Nuclear Medicine & Molecular Imaging 51 (5): 1409–20. doi:10.1007/s00259-023-06528-2.